Results 111 to 120 of about 49,423 (253)

Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study

Journal of Cosmetic Dermatology, Volume 24, Issue 5, May 2025.
ABSTRACT Background Alopecia areata is an autoimmune disease in which T cells may play a key role in its pathogenesis. Various immunosuppressive drugs have been employed with varying degrees of success. Objectives This study aimed to evaluate the long‐term efficacy and safety of azathioprine as a systemic monotherapy for moderate to severe alopecia ...
Susan Farshi, Parvin Mansouri
wiley   +1 more source

The Ultimate Synonym Group [PDF]

, 1987
What is the most talked-about subject in the English-speaking world today? Baldness! How do I know?
Borgmann, Dmitri A.
core   +1 more source

SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Ziad Reguiai, Leila Asfour, Delphine Staumont‐Sallé, Ángela Hermosa‐Gelbard, Andrea Sechi, Dalia Wajsbrot, Rahmat Ishowo‐Adejumo, Deborah Woodworth, Alexandre Lejeune   +8 more
wiley   +1 more source

Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial

The Journal of Dermatology, Volume 52, Issue 4, Page 603-614, April 2025.
Abstract This subgroup analysis of the ALLEGRO phase 2b/3 study (NCT3732807) assessed the efficacy and safety of multiple doses of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in Asian patients with alopecia areata (AA). Patients aged ≥12 years with AA and ≥50% scalp hair loss received once‐daily ritlecitinib 50 or 30 mg (with or without 4 ...
Xingqi Zhang, Yanting Ye, Weiling Sun, Youyu Sheng, Misaki Kinoshita‐Ise, Taisuke Ito, Cheng‐Che Lan, Ohsang Kwon, Gregor Schaefer, Robert Wolk, Shasha Hu, Qiankun Sun, Yimeng Shen, Masayo Sakaki‐Yumoto   +13 more
wiley   +1 more source

Introduction to Innovations in the Immunology and Clinical Science of Alopecia Areata [PDF]

, 2013
Alopecia areata is an autoimmune skin disease resulting in the loss of hair on the scalp and elsewhere on the body. The disease most often occurs in childhood and affects males and females of all ages.
Bergfeld, Wilma F., Christiano, Angela M., Kalabokes, Victoria D.   +2 more
core   +1 more source

Treatments for alopecia areata: a network meta-analysis [PDF]

, 2020
Acknowledgement: “This Protocol of a Cochrane Review was published in the Cochrane Database of Systematic Reviews 2020, Issue 9. Cochrane Protocols and Reviews are regularly updated as new evidence emerges and in response to feedback, and the Cochrane ...
Arevalo-Rodriguez, I, Giraldo, L, Novoa-Candia, M, Ortega-Quijano, D, Saceda-Corralo, D, Sánchez Vanegas, G, Tobias, A, Tomlinson, J, Urueña Rodriguez, MG, Vaño-Galván, S, Zamora, J   +10 more
core   +1 more source

Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2

Dermatology and Therapy, 2023
Background Baricitinib, an oral selective JAK1/JAK2 inhibitor, is approved for the treatment of adults with severe alopecia areata (AA). Objective To evaluate differences in response up to week 52 among subgroups based on the baseline severity of AA ...
Susan Taylor, Neil J. Korman, Tsen-Fang Tsai, Yutaka Shimomura, Meghan Feely, Yves Dutronc, Wen-Shuo Wu, Najwa Somani, Antonella Tosti   +8 more
doaj   +1 more source

Investigating Alopecia Areata and its Connection to The High-Mobility Group Box 1: Review Article [PDF]

, 2022
Background: It is a common and reversible hair loss illness known as alopecia areata (AA). Hair loss on the scalp and other regions of the body can begin as a patchy area of full hair loss which may develop to the entire loss of all hair on the body.
El Ghareeb , Mohamed Ibrahim, El-Sayed, Asmaa Abd El-Hameed, Ghanem, Afaf Helmy   +2 more
core   +1 more source

Alopecia Totalis Treated with 1064 nm Picosecond Nd:YAG Laser: A Case Report

Applied Sciences, 2019
Alopecia areata (AA) is an autoimmune disorder causing nonscarring hair loss. Alopecia totalis (AT), the severe form of AA, is usually refractory to many first-line treatments including topical and intralesional corticosteroids and topical immunotherapy.
Shiow-Jen Juang, Tsung-Hua Tsai, Shu-Hui Wang, Ching-Chi Chi   +3 more
doaj   +1 more source

The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study

Journal of Cosmetic Dermatology, Volume 24, Issue 4, April 2025.
ABSTRACT Background Scant evidence exists for the relative efficacy of therapies for alopecia areata (AA)—including those approved by the Food and Drug Administration, namely, baricitinib, deuruxolitinib, and ritlecitinib. Aims We determined the relative efficacy and safety of monotherapy with janus kinase inhibitors (JAKIs), apremilast, and dupilumab.
Aditya K. Gupta, Mary A. Bamimore, Paradi Mirmirani, Vincent Piguet, Mesbah Talukder   +4 more
wiley   +1 more source